These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 2467845)

  • 1. Weekly cisplatin induction chemotherapy in the treatment of recurrent cervical carcinoma.
    Lele SB; Piver MS
    Gynecol Oncol; 1989 Apr; 33(1):6-8. PubMed ID: 2467845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensive sequential chemotherapy with bleomycin, Oncovin, mitomycin C, and methotrexate followed by adriamycin, cisplatin, and cyclosphosphamide in squamous cell cancer of the head and neck.
    Wheeler RH; Baker SR; Liepman MK; Ensminger WD
    Med Pediatr Oncol; 1983; 11(1):12-9. PubMed ID: 6188032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase II trial of mitomycin, vincristine, bleomycin, and cisplatin (MOBP) as neoadjuvant therapy in high-risk cervical carcinoma.
    Weiner SA; Aristizabal S; Alberts DS; Surwit EA; Deatherage-Deuser K
    Gynecol Oncol; 1988 May; 30(1):1-6. PubMed ID: 2452769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bleomycin, vincristine, mitomycin C, and cis-platinum in gynecologic squamous cell carcinomas: a high incidence of pulmonary toxicity.
    Chambers SK; Flynn SD; Del Prete SA; Chambers JT; Schwartz PE
    Gynecol Oncol; 1989 Mar; 32(3):303-9. PubMed ID: 2465939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy for advanced and/or recurrent cervical cancer.
    Lahousen M; Pickel H; Tamussino K
    Arch Gynecol; 1987; 240(4):247-52. PubMed ID: 2440389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bleomycin, vincristine, mitomycin-C, and cisplatin in the management of gynecological squamous cell carcinomas.
    Belinson JL; Stewart JA; Richards AL; McClure M
    Gynecol Oncol; 1985 Mar; 20(3):387-93. PubMed ID: 2579010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of consecutive low-dose cisplatin with bleomycin, vincristine, and mitomycin for recurrent cervical carcinoma.
    Shimizu Y; Akiyama F; Umezawa S; Ishiya T; Utsugi K; Hasumi K
    J Clin Oncol; 1998 May; 16(5):1869-78. PubMed ID: 9586903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chemotherapy of cancers of the uterine cervix with a combination of bleomycin, mitomycin, cisplatin and etoposide].
    Chauvergne J; Héron JF; Mayer F; Charrot-Chinet P; Toulouse C
    Bull Cancer; 1993 Jan; 80(1):70-9. PubMed ID: 7515729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination chemotherapy for patients with advanced carcinoma of the cervix: trial of mitomycin-C, vincristine, bleomycin, and cisplatin.
    Giannone L; Brenner DE; Jones HW; Greco FA; Burnett LS
    Gynecol Oncol; 1987 Feb; 26(2):178-82. PubMed ID: 2433196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy for recurrent and metastatic cervical cancer with standard-dose methotrexate-leucovorin, bleomycin and cis-platinum.
    Vogl SE; Seltzer V; Camacho F; Davis TE
    J Reprod Med; 1986 May; 31(5):327-9. PubMed ID: 2427717
    [No Abstract]   [Full Text] [Related]  

  • 11. Bleomycin, mitomycin, and cisplatin therapy for advanced squamous carcinoma of the uterine cervix: a phase II study of the Northern California Oncology Group.
    Picozzi VJ; Sikic BI; Carlson RW; Koretz M; Ballon SC
    Cancer Treat Rep; 1985; 69(7-8):903-5. PubMed ID: 2410123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined chemotherapy using cisplatin, ifosfamide and bleomycin (PIB) in the treatment of advanced and recurrent cervical carcinoma.
    Tay SK; Lai FM; Soh LT; Ho TH; Ang PT; Au E
    Aust N Z J Obstet Gynaecol; 1992 Aug; 32(3):263-6. PubMed ID: 1280100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cis-platinum and mitomycin-C in treatment of recurrent, metastatic, or residual uterine cervical cancer post radiation.
    Senapad S; Neungton S; Usavajindawath C; Vijatrasil S; Thaithanaisawanya V
    J Med Assoc Thai; 1989 Jul; 72(7):382-6. PubMed ID: 2507723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The immediate results of the combined chemotherapy of disseminated forms and recurrences of cervix uteri cancer with vincristine, platidiam and adriamycin].
    Zabunov AV; Dudareva LA
    Vopr Onkol; 1991; 37(11-12):1090-4. PubMed ID: 1669203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weekly cis-diamminedichloroplatinum II as induction chemotherapy in recurrent carcinoma of the cervix.
    Piver MS; Barlow JJ; Lele SB; Maniccia M
    Gynecol Oncol; 1984 Jul; 18(3):313-9. PubMed ID: 6540221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of advanced or recurrent cervical cancer by a new BOMP regimen consisting of bleomycin, vincristine, mitomycin-C, and low-dose consecutive cisplatin].
    Shimizu Y; Nakayama K; Seimiya Y; Yamakawa Y; Koi S; Yokosuka K; Teshima H; Chen JT; Fujimoto I; Yamauchi K
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 May; 43(5):549-56. PubMed ID: 1711555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II randomized trial of cisplatin chemotherapy regimens in the treatment of recurrent or metastatic squamous cell cancer of the cervix: a Southwest Oncology Group Study.
    Alberts DS; Kronmal R; Baker LH; Stock-Novack DL; Surwit EA; Boutselis JG; Hannigan EV
    J Clin Oncol; 1987 Nov; 5(11):1791-5. PubMed ID: 2445932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy in recurrent and advanced cervical cancer.
    Kumar L; Bhargava VL
    Gynecol Oncol; 1991 Feb; 40(2):107-11. PubMed ID: 1707022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II evaluation of cisplatin, bleomycin, and mitomycin-C in patients with recurrent squamous cell carcinoma of the cervix.
    Hoffman MS; Kavanagh JJ; Roberts WS; LaPolla JP; Fiorica JV; Hewitt S; Cavanagh D
    Gynecol Oncol; 1991 Feb; 40(2):144-6. PubMed ID: 1707024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination chemotherapy with cisplatin and bleomycin in advanced cervical cancer.
    Bloch B; Nel CP; Kriel A; Atad J; Goldberg G
    Cancer Treat Rep; 1984 Jun; 68(6):891-3. PubMed ID: 6203640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.